Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep - Excellent Survival Data from INSIGHT-003 Trial in NSCLC (ASX:IMM)

-- Mature data in patients with a minimum follow-up of 22 months (N=21) shows excellent results, well above historical controls and exceeding expectations: ---- Median Overall Survival is 32.9...read more

BluGlass secures A$2.9M CLAWS Hub sub-contract (ASX:BLG)

-- BluGlass and North Carolina State University (NCSU) have entered a US$1.925 million (AU$2.9 million) contract as part of the US Department of Defense’s US$2 billion Microelectronics Commons...read more

Immutep - Positive Data from Phase II Trial in Soft Tissue Sarcoma (ASX:IMM)

-- Efti in combination with pembrolizumab and radiotherapy demonstrates significant efficacy in the neoadjuvant setting in patients with soft tissue sarcoma -- Over three-fold increase in tumour hy...read more

Lithium Universe - Amendment to Placement and Launch of Entitlement Offer (ASX:LU7)

Lithium Universe Limited (referred to as "Lithium Universe" or the "Company," ASX: "LU7”) refers to its announcement made on 30 October 2024 concerning its share place...read more

Lithium Universe - Quarterly Activities/Appendix 5B Cash Flow Report (ASX:LU7)

The Lithium Universe Strategy Positive, robust Bécancour Refinery PFS even in low pricing environment LU7 has a counter cyclical strategy – develop project, ready for pric...read more

BluGlass - Quarterly Activities Report / Appendix 4C - 30 Sept 2024 (ASX:BLG)

Highlights Secured A$1.2 million for the first phase of a multi-year Joint Development Agreement with a US venture-backed start-up pioneering wide bandgap semiconductors and integrated photo...read more

Dotz Nano - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:DTZ)

Key highlights of third quarter and recent weeks: Successful lab-scale pilot demonstration of DotzEarth, reconfirming superior performance compared with commercial activated carbon and advan...read more

INOVIQ - Quarterly Business Update and Appendix 4C - September 2024 (ASX:IIQ)

Lodging this quarterly update, Chairman David Williams said: “Progress continued across our commercial, development and corporate activities. Promega is gaining new EXO-NET customers and there...read more

BPH Energy - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:BPH)

On 15 August 2024 the Company announced that it had issued 57,932,781 new fully paid ordinary shares (“Placement Shares”) in the Company at an issue price of $0.018 per share. Placement ...read more

Lithium Universe Completes Share Placement and Launches Entitlement Offer (ASX:LU7)

Highlights Binding commitments received to raise $2.14 million Launch of pro-rata Non-Renounceable Entitlement Offer to raise $1.02 million Issue price of the Placement and Entit...read more

Sequoia Financial Group - Investor Presentation (ASX:SEQ)

To see the presentation, download the attached PDF.

Immutep Quarterly Activities Report and Appendix 4C (ASX:IMM)

Key points: Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding regulatory preparations for the ...read more

Altech Batteries - Quarterly Activities/Appendix 5B Cash Flow Report (ASX:ATC)

Highlights CERENERGY 60kWh Prototype Completed CERENERGY 60kWh prototype completed and operating Undergoing daily testing with battery test station at Dresden Outperforme...read more

Western Yilgarn - Quarterly Report and Appendix 5B - September 2024 (ASX:WYX)

Ida Holmes Project Exploration activities at the Ida Holmes Project will be fast tracked following positive airborne electromagnetic (EM) survey results at the Ida Holmes Junction (IHJ) pros...read more